Two Sigma Advisers’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-191,201
| Closed | -$241K | – | 1505 |
|
|
2025
Q4 | $241K | Sell |
191,201
-152,896
| -44% | -$213K | ﹤0.01% | 2050 |
|
|
2025
Q3 | $533K | Sell |
344,097
-304,200
| -47% | -$418K | ﹤0.01% | 1736 |
|
|
2025
Q2 | $856K | Buy |
648,297
+96,600
| +18% | +$132K | ﹤0.01% | 1515 |
|
|
2025
Q1 | $916K | Buy |
551,697
+170,500
| +45% | +$281K | ﹤0.01% | 1510 |
|
|
2024
Q4 | $560K | Buy |
381,197
+8,396
| +2% | +$12.8K | ﹤0.01% | 1738 |
|
|
2024
Q3 | $555K | Sell |
372,801
-89,600
| -19% | -$133K | ﹤0.01% | 1657 |
|
|
2024
Q2 | $578K | Sell |
462,401
-730,396
| -61% | -$947K | ﹤0.01% | 1818 |
|
|
2024
Q1 | $1.43M | Buy |
1,192,797
+55,900
| +5% | +$55.9K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $1.72M | Sell |
1,136,897
-176,200
| -13% | -$255K | ﹤0.01% | 1377 |
|
|
2023
Q3 | $2.1M | Sell |
1,313,097
-126,100
| -9% | -$230K | 0.01% | 1176 |
|
|
2023
Q2 | $3.12M | Sell |
1,439,197
-358,100
| -20% | -$560K | 0.01% | 971 |
|
|
2023
Q1 | $2.62M | Sell |
1,797,297
-465,700
| -21% | -$599K | 0.01% | 1134 |
|
|
2022
Q4 | $2.83M | Buy |
2,262,997
+140,600
| +7% | +$222K | 0.01% | 1047 |
|
|
2022
Q3 | $4.01M | Buy |
2,122,397
+1,275,600
| +151% | +$3.02M | 0.01% | 847 |
|
|
2022
Q2 | $2.14M | Buy |
846,797
+504,597
| +147% | +$1.47M | 0.01% | 1181 |
|
|
2022
Q1 | $1.18M | Buy |
342,200
+60,900
| +22% | +$215K | ﹤0.01% | 1550 |
|
|
2021
Q4 | $1.35M | Buy |
281,300
+261,000
| +1,286% | +$1.06M | ﹤0.01% | 1389 |
|
|
2021
Q3 | $74K | Sell |
20,300
-92,600
| -82% | -$345K | ﹤0.01% | 2347 |
|
|
2021
Q2 | $457K | Sell |
112,900
-76,000
| -40% | -$298K | ﹤0.01% | 1974 |
|
|
2021
Q1 | $810K | Buy |
+188,900
| New | +$902K | ﹤0.01% | 1768 |
|
|
2020
Q3 | – | Sell |
-908,632
| Closed | -$3.1M | – | 2573 |
|
|
2020
Q2 | $3.1M | Sell |
908,632
-319,700
| -26% | -$716K | 0.01% | 994 |
|
|
2020
Q1 | $1.65M | Buy |
1,228,332
+793,227
| +182% | +$1.24M | 0.01% | 1216 |
|
|
2019
Q4 | $640K | Buy |
+435,105
| New | +$728K | ﹤0.01% | 1764 |
|
|
2019
Q3 | – | Sell |
-14,025
| Closed | -$34K | – | 2350 |
|
|
2019
Q2 | $34K | Buy |
+14,025
| New | +$30.6K | ﹤0.01% | 2272 |
|
|
2019
Q1 | – | Sell |
-16,400
| Closed | -$49K | – | 2418 |
|
|
2018
Q4 | $49K | Buy |
+16,400
| New | +$55.6K | ﹤0.01% | 2278 |
|
|
2015
Q3 | – | Sell |
-81,211
| Closed | -$1.31M | – | 1928 |
|
|
2015
Q2 | $1.31M | Buy |
+81,211
| New | +$1.26M | 0.01% | 994 |
|
|
2014
Q4 | – | Sell |
-28,600
| Closed | -$243K | – | 2680 |
|
|
2014
Q3 | $243K | Buy |
+28,600
| New | +$251K | ﹤0.01% | 2025 |
|
Other funds holding OPK
RCMNY
WCM
Two Sigma Advisers's OPK Position: Q1 2026 in Review
Two Sigma Advisers sold out of Opko Health (OPK) in Q1 2026, closing a stake of 191,201 shares — an estimated $241K sold.
Two Sigma Advisers first reported a position in OPK in Q3 2014 and held it in 27 quarters. The position peaked at $4.01M in Q3 2022. 236 funds tracked by Wall St. Rank hold OPK as of Q1 2026.
- Two Sigma Advisers reported no remaining Opko Health position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 191,201 Opko Health shares in Q1 2026, an estimated $241K.
- Two Sigma Advisers first reported a position in Opko Health in Q3 2014 and held it in 27 quarters.
- Two Sigma Advisers's Opko Health position peaked at $4.01M in Q3 2022.
- 236 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.